HOG
35
2
PRGO
39
3
PG
56
5
DVN
21
3
ADSK
70
2
LMT
34
2
YUM
47
3
NRG
49
-3
ORLY
62
2
LEG
36
4
FSLR
54
7
IR
66
3
IPG
56
3
WY
54
4
ROP
62
3
HAS
33
3
SE
61
-4
AXP
71
2
LB
63
22
PFG
45
3
HOG
35
2
PRGO
39
3
PG
56
5
DVN
21
3
ADSK
70
2
LMT
34
2
YUM
47
3
NRG
49
-3
ORLY
62
2
LEG
36
4
FSLR
54
7
IR
66
3
IPG
56
3
WY
54
4
ROP
62
3
HAS
33
3
SE
61
-4
AXP
71
2
LB
63
22
PFG
45
3
Financhill
Back

Dermata Therapeutics Vs. NeuroBo Pharmaceuticals Industry Stock Comparison

Sell
20

DRMA
Dermata Therapeutics

Last Price:
1.11
Seasonality Move:
-52.03%
Sell
22

NRBO
NeuroBo Pharmaceuticals

Last Price:
2.40
Seasonality Move:
6.18%
Sell
20
Dermata Therapeutics (DRMA) is a Sell

Is Dermata Therapeutics a Buy, Sell or Hold?

  • The current Dermata Therapeutics [DRMA] share price is $1.14. The Score for DRMA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
NeuroBo Pharmaceuticals (NRBO) is a Sell

Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?

  • The current NeuroBo Pharmaceuticals [NRBO] share price is $2.37. The Score for NRBO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • NRBO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DRMA Stock Price Chart

What is Dermata Therapeutics's stock price today?

  • The Dermata Therapeutics share price today is $1.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NRBO Stock Price Chart

What is NeuroBo Pharmaceuticals's stock price today?

  • The NeuroBo Pharmaceuticals share price today is $2.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.

DRMA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 21797 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.16 - 1.44) Sell
Bollinger Bands (100): (1.28 - 2.18) Sell

NRBO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 40.38 Sell
Chaikin Money Flow: -15734 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.81) Sell
Bollinger Bands (100): (2.68 - 4.12) Sell

DRMA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.14 Sell
20-day SMA: 1.25 Sell
50-day SMA: 1.44 Sell
200-day SMA: 3.36 Sell
8-day EMA: 1.16 Sell
20-day EMA: 1.24 Sell
50-day EMA: 1.44 Sell
200-day EMA: 6.18 Sell

NRBO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.38 Sell
20-day SMA: 2.56 Sell
50-day SMA: 2.81 Sell
200-day SMA: 3.85 Sell
8-day EMA: 2.41 Sell
20-day EMA: 2.53 Sell
50-day EMA: 2.82 Sell
200-day EMA: 4.7 Sell

Dermata Therapeutics Earnings Growth & DRMA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dermata Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NeuroBo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):